ClinicalTrials.Veeva

Menu

Sentinel Node With Ultrasound Contrast in Melanoma

Rigshospitalet logo

Rigshospitalet

Status

Completed

Conditions

Malignant Melanoma

Treatments

Drug: ultrasound contrast

Study type

Interventional

Funder types

Other

Identifiers

NCT00370136
(KF)01288200

Details and patient eligibility

About

The purpose is to evaluate,in 20 patients, if the sentinel node(s) in melanoma can be detected by lymph contrast ultrasound. In comparing the patients will also get lymph-scintigraphy and sentinel node detection wiht blue dye.

The goal is to improve the method for detecting sentinel node(s) in melanoma.

Enrollment

20 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Malignant melanoma on a extremity,
  • No spread of the cancer,
  • Patients over 18 years old,

Exclusion criteria

  • Pregnancy,
  • Lactating,
  • Severe hart disease,

Trial design

Primary purpose

Diagnostic

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

Single Blind

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems